Review
[Pharmacotherapy in ovarian carcinoma]
[Article in
German]
Affiliations
- PMID: 16302419
Item in Clipboard
Review
[Pharmacotherapy in ovarian carcinoma]
[Article in
German]
MMW Fortschr Med.
.
Abstract
Pharmacotherapy in Ovarian Carcinoma Although recent years have seen considerable progress in the treatment of primary and recurrent ovarian carcinoma, the mortality rate continues to be very high. Possibilities for improvement include compliance with the current treatment recommendations both in the surgical and medical areas, as well as the participation in clinical studies or treatment in study centers.
Similar articles
-
Recent advances in the management of women with ovarian cancer.Minerva Ginecol. 2004 Feb;56(1):81-9. Minerva Ginecol. 2004. PMID: 14973412 Review.
-
Chemotherapy for ovarian cancer: an evidence-based approach.Minerva Ginecol. 2004 Dec;56(6):539-45. Minerva Ginecol. 2004. PMID: 15729206 Review.
-
Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.J Natl Compr Canc Netw. 2004 Sep;2 Suppl 2:S60-73. J Natl Compr Canc Netw. 2004. PMID: 19780247 Review.
-
[Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].Zentralbl Gynakol. 1997;119(7):299-323. Zentralbl Gynakol. 1997. PMID: 9340970 Review. German.
-
Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.Acta Obstet Gynecol Scand. 2008;87(12):1343-52. doi: 10.1080/00016340802495491. Acta Obstet Gynecol Scand. 2008. PMID: 18951208
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical